Adaptive Biotechnologies
ADPT
ADPT
225 hedge funds and large institutions have $1.14B invested in Adaptive Biotechnologies in 2025 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 73 increasing their positions, 67 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
9% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 67
3% more call options, than puts
Call options by funds: $383K | Put options by funds: $372K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
225
Holding in Top 10
1
Calls
$383K
Puts
$372K
Top Buyers
| 1 | +$43.9M | |
| 2 | +$35.7M | |
| 3 | +$15.9M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$13M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$9.7M |
Top Sellers
| 1 | -$24.5M | |
| 2 | -$22.1M | |
| 3 | -$12.6M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$11M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$7.91M |
